Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsushi Goda

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
NPJ Microgravity|July 21, 2017
Microlayered flow structure around an acoustically levitated droplet under a phase-change processKoji Hasegawa, Yutaka Abe, Atsushi Goda
Breast Cancer Research : BCR|October 21, 2024
Ribosomal S6 kinase (RSK) plays a critical role in DNA damage response via the phosphorylation of histone lysine demethylase KDM4BWenwen Wu, Jing Zhu, Naoe Taira Nihira, et al.
Breast Cancer Research and Treatment|January 5, 2024
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinomaSaki Nakagawa, Minoru Miyashita, Ichiro Maeda, et al.
The Journal of Clinical Investigation|November 13, 2018
Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancerYoshikazu Johmura, Ichiro Maeda, Narumi Suzuki, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
NPJ Microgravity|July 21, 2017
Microlayered flow structure around an acoustically levitated droplet under a phase-change processKoji Hasegawa, Yutaka Abe, Atsushi Goda
Breast Cancer Research : BCR|October 21, 2024
Ribosomal S6 kinase (RSK) plays a critical role in DNA damage response via the phosphorylation of histone lysine demethylase KDM4BWenwen Wu, Jing Zhu, Naoe Taira Nihira, et al.
Breast Cancer Research and Treatment|January 5, 2024
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinomaSaki Nakagawa, Minoru Miyashita, Ichiro Maeda, et al.
The Journal of Clinical Investigation|November 13, 2018
Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancerYoshikazu Johmura, Ichiro Maeda, Narumi Suzuki, et al.
Pageof 1